Literature DB >> 7672054

Risk factors for chronic obstructive pulmonary disease in a north Italian rural area.

G Viegi1, L Carrozzi, F Di Pede, S Baldacci, M Pedreschi, P Modena, P Paoletti.   

Abstract

To assess the role of risk factors for chronic obstructive lung disease (COPD) by multiple logistic models, the data of the first cross-sectional epidemiological survey in the unpolluted rural area of the Po River Delta were analyzed (n = 2382; 20-64 years). Each subject filled out a standardized questionnaire; 94% of the subjects were also able to perform forced expirograms. Dependent variables were chronic respiratory symptoms, asthma, abnormal parameters of flow-volume curve (ABNFVC), and a complex characterized by chronic phlegm, and/or any wheeze and/or dyspnea grade 2+ and/or diagnosis of asthma and/or an FEV1/FVC ratio less than 60% (ANYABN). Independent variables were: age, ever cigarette smoking (SMK) and lifetime cigarette consumption expressed as pack-years, childhood respiratory infections (CRI), adolescence-adulthood respiratory infections (ARI), familial history for COPD (FCOPD) or for asthma/allergies (FASTHMA), work exposure to dusts/chemicals (EXPO), low socio-economic conditions (SES). A significant relationship with almost all dependent variables was shown by pack-years, ARI and age in both sexes. In males, FCOPD was related to chronic mucus hypersecretion and to ABNFVC, FASTHMA was associated with wheeze and ANYABN. EXPO was related to dyspnea and asthmatic symptoms in both sexes and also to bronchitic symptoms in males. CRI was a significant contributor for asthma symptoms in males, for ANYABN in females. SES had no significant association. In conclusion, our findings show that, beside lifetime cigarette smoking, other host--or environment--related conditions are important risk factors for COPD, suggesting the need for a more thorough strategy for prevention.

Entities:  

Mesh:

Year:  1994        PMID: 7672054     DOI: 10.1007/bf01719289

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Effects of childhood and adolescence-adulthood respiratory infections in a general population.

Authors:  P Paoletti; R Prediletto; L Carrozzi; G Viegi; F Di Pede; G Carmignani; U Mammini; C Giuntini; M D Lebowitz
Journal:  Eur Respir J       Date:  1989-05       Impact factor: 16.671

2.  The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample.

Authors:  B Rijcken; J P Schouten; S T Weiss; F E Speizer; R van der Lende
Journal:  Am Rev Respir Dis       Date:  1987-07

3.  Quantitative relationships between cigarette smoking and ventilatory function.

Authors:  B Burrows; R J Knudson; M G Cline; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1977-02

4.  Factors associated with bronchial responsiveness to histamine in a population sample of adults.

Authors:  B Rijcken; J P Schouten; T T Mensinga; S T Weiss; K De Vries; R Van der Lende
Journal:  Am Rev Respir Dis       Date:  1993-06

5.  Respiratory effects of occupational exposure in a general population sample in north Italy.

Authors:  G Viegi; R Prediletto; P Paoletti; L Carrozzi; F Di Pede; M Vellutini; C Di Pede; C Giuntini; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1991-03

6.  Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 11 North American and Western European countries.

Authors:  N B Pride; P Vermeire; L Allegra
Journal:  Eur Respir J       Date:  1989-09       Impact factor: 16.671

7.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.

Authors:  R Peto; F E Speizer; A L Cochrane; F Moore; C M Fletcher; C M Tinker; I T Higgins; R G Gray; S M Richards; J Gilliland; B Norman-Smith
Journal:  Am Rev Respir Dis       Date:  1983-09

8.  The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study.

Authors:  M Krzyzanowski; M Wysocki
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

9.  Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample.

Authors:  R Dodge; M G Cline; B Burrows
Journal:  Am Rev Respir Dis       Date:  1986-06

10.  A reexamination of risk factors for ventilatory impairment.

Authors:  B Burrows; R J Knudson; M G Cline; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1988-10
View more
  4 in total

1.  Serum immunoglobulins E are related to menstrual cycle.

Authors:  M Vellutini; G Viegi; D Parrini; M Pedreschi; S Baldacci; P Modena; P Biavati; M Simoni; L Carrozzi; C Giuntini
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

2.  Identification of trans Protein QTL for Secreted Airway Mucins in Mice and a Causal Role for Bpifb1.

Authors:  Lauren J Donoghue; Alessandra Livraghi-Butrico; Kathryn M McFadden; Joseph M Thomas; Gang Chen; Barbara R Grubb; Wanda K O'Neal; Richard C Boucher; Samir N P Kelada
Journal:  Genetics       Date:  2017-08-29       Impact factor: 4.562

3.  Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.

Authors:  Akkelies E Dijkstra; H Marike Boezen; Maarten van den Berge; Judith M Vonk; Pieter S Hiemstra; R Graham Barr; Kirsten M Burkart; Ani Manichaikul; Tess D Pottinger; Edward K Silverman; Michael H Cho; James D Crapo; Terri H Beaty; Per Bakke; Amund Gulsvik; David A Lomas; Yohan Bossé; David C Nickle; Peter D Paré; Harry J de Koning; Jan-Willem Lammers; Pieter Zanen; Joanna Smolonska; Ciska Wijmenga; Corry-Anke Brandsma; Harry J M Groen; Dirkje S Postma
Journal:  Eur Respir J       Date:  2014-09-18       Impact factor: 16.671

4.  Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Authors:  Akkelies E Dijkstra; Joanna Smolonska; Maarten van den Berge; Ciska Wijmenga; Pieter Zanen; Marjan A Luinge; Mathieu Platteel; Jan-Willem Lammers; Magnus Dahlback; Kerrie Tosh; Pieter S Hiemstra; Peter J Sterk; Avi Spira; Jorgen Vestbo; Borge G Nordestgaard; Marianne Benn; Sune F Nielsen; Morten Dahl; W Monique Verschuren; H Susan J Picavet; Henriette A Smit; Michael Owsijewitsch; Hans U Kauczor; Harry J de Koning; Eva Nizankowska-Mogilnicka; Filip Mejza; Pawel Nastalek; Cleo C van Diemen; Michael H Cho; Edwin K Silverman; James D Crapo; Terri H Beaty; David A Lomas; Per Bakke; Amund Gulsvik; Yohan Bossé; Ma'en Obeidat; M A Obeidat; Daan W Loth; Lies Lahousse; Fernando Rivadeneira; Andre G Uitterlinden; Andre Hofman; Bruno H Stricker; Guy G Brusselle; Cornelia M van Duijn; Uilke Brouwer; Gerard H Koppelman; Judith M Vonk; Martijn C Nawijn; Harry J M Groen; Wim Timens; H Marike Boezen; Dirkje S Postma
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.